• Belgian biotech in European Top-3 despite turbulent times

    Wednesday May 18th 2022

  • flanders.bio appoints CEO and COO in newly created role

    Wednesday May 18th 2022

  • Spearhead cluster flanders.healthTech turns into MEDVIA and is ready to make a change in healthcare innovation

    Tuesday May 17th 2022

  • QbD Group requalifies as Best Managed Company

    Friday May 13th 2022

  • Augustine Therapeutics appoints Gerhard Koenig as Chairman of the Board, forms Clinical Advisory Board, and broadens therapeutic indications

    Tuesday May 10th 2022

  • Quality by Design (QbD) becomes QbD Group, consolidating its offerings to support the development of innovative life science products, “from idea to patient”

    Monday May 9th 2022

  • The European Spatial Biology Center (ESBC): State-of-the-art spatial biology services enabled at scale in Leuven

    Thursday May 5th 2022

  • Flanders launches new tech ecosystem platform to connect start-ups to investors

    Friday April 29th 2022

  • Your news here?

  • Kantify and I-Stem Use Artificial Intelligence to discover a promising therapy against a rare disease

    Wednesday April 27th 2022

  • flanders.bio zet Vlaamse agro-voedingstechnologie op de internationale kaart

    Tuesday April 26th 2022

  • Kantify announces its new breakthrough AI technology for drug discovery

    Thursday March 31st 2022


Strategic Partners